SEROTONIN 5-HT2B INHIBITOREN

European patent · EP4376818 · In force

Register entry

Publication number
EP4376818
Application number
EP22754608
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 15, 2022
Published
Jun 5, 2024
Granted
Jun 18, 2025
Protection ends at the latest
Jul 14, 2042
Next annual fee due
Jul 31, 2027
IPC classes
A61K 31/00 (2006.01)
A61K 45/00 (2006.01)
A61P 35/00 (2006.01)
C07D 201/00 (2006.01)
C07D 451/02 (2006.01)
C12Q 1/6804 (2018.01)
C12Q 1/6806 (2018.01)
C12Q 1/686 (2018.01)
C12Q 1/689 (2018.01)
Priority
US 202163225775 P 26.07.2021
PCT application
PCT/US2022/037255 15.07.2022
PCT publication
WO2023/009330 02.02.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Apr 30, 2026

    Change

    Published in Swissreg on 30.04.2026

  3. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  4. Jun 26, 2025

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 26.06.2025

  5. Jun 18, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 18.06.2025

Parties

Inventor

EWIN, Richard A.

Kalamazoo, Michigan 49007, US

FENWICK, Ashley E.

Kalamazoo, Michigan 49007, US

SUBRAMANIAN, Govindan

Kalamazoo, Michigan 49007, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.